Home › Funds › Soleus Capital Management, L.P. › AXGN

Soleus Capital Management, L.P. position in AXGN

AXOGEN INC · Health Care

Soleus Capital Management, L.P. reported holding 1,081,000 shares of AXGN (AXOGEN INC) in its Q3 2026 13F filing — a position valued at US$45.3M, representing 1.61% of its reported portfolio and ranking #16 among its reported holdings. Soleus Capital Management, L.P. has disclosed AXGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.08M sh
Reported value held$45.32M
Portfolio Weight1.61%
First reportedQ3 2023
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Soleus Capital Management, L.P.'s AXGN position evolved

Soleus Capital Management, L.P. first disclosed a stake in AXGN in Q3 2023 at 3,785,829 shares (US$18.9M). The position peaked in Q4 2024 at 2,955,943 shares, worth US$48.7M. Across 13 filings, Soleus Capital Management, L.P. increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,081,000 shares valued at US$45.3M — an increase of 1,023,964 shares quarter over quarter.. Notable position changes include a 51% trim in Q1 2025 (shares fell 41% over the following quarter), a 92% trim in Q2 2026 (shares fell 9% over the following quarter), a 1795% increase in Q3 2026 (shares rose 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.79M $18.93M New
Q4 2023 2.60M $17.73M Reduce
Q1 2024 3.11M $25.06M Add
Q2 2024 3.31M $23.93M Add
Q3 2024 3.01M $42.14M Reduce
Q4 2024 2.96M $48.71M Reduce
Q1 2025 1.45M $26.75M Reduce
Q2 2025 1.46M $15.83M Add
Q3 2025 1.73M $30.80M Add
Q4 2025 1.21M $39.50M Reduce
Q1 2026 679.17K $22.50M Reduce
Q2 2026 57.04K $2.63M Reduce
Q3 2026 1.08M $45.32M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AXGN and 13F data

AXGN (AXOGEN INC) is a Health Care company. 59 other funds we track also report a position in AXGN — the largest reported positions include First Light Asset Management, LLC (US$156.7M), Hood River Capital Management LLC (US$98.3M), RTW INVESTMENTS, LP (US$69.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AXGN

All AXGN fund holders →

FAQ

How long has Soleus Capital Management, L.P. held AXGN?

Soleus Capital Management, L.P. has disclosed AXGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Soleus Capital Management, L.P.'s current position in AXGN?

As of Q3 2026, Soleus Capital Management, L.P. holds 1.08M shares of AXGN (AXOGEN INC), valued at $45.32M, representing 1.61% of its reported portfolio and ranking #16.

Has Soleus Capital Management, L.P. been buying or selling AXGN?

In the latest 13F filing (Q3 2026), Soleus Capital Management, L.P. increased its position in AXGN. The position peaked in Q4 2024 at 2.96M shares.

Which other funds hold AXGN?

Other major institutional holders of AXGN include First Light Asset Management, LLC, Hood River Capital Management LLC, RTW INVESTMENTS, LP, among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.